Guerbet (GBT) Q1 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 TU earnings summary
6 Jun, 2025Executive summary
Q1 2025 revenue reached €180.1m, down 7.3% year-over-year, mainly due to a penalizing base effect and persistent impact in France.
Revenue at constant exchange rates (CER) and like-for-like basis declined 7.1% compared to Q1 2024.
Annual targets for revenue growth and profitability are confirmed, with expectations of improved performance in H2 2025.
Financial highlights
EMEA sales fell 4.5% at CER and like-for-like, driven by a 21.2% drop in France; excluding France, EMEA grew 4.3%.
Americas sales decreased 2.4% at CER and like-for-like, impacted by high prior-year restocking.
Asia sales dropped 16.3% at CER and like-for-like, affected by a strong comparison base and order postponements in Vietnam.
Free Cash Flow remains positive.
Outlook and guidance
Full-year 2025 revenue growth expected between 3% and 5% at CER and like-for-like.
Restated EBITDA margin projected to exceed 15% for 2025.
H1 2025 expected to be stable at best, with acceleration anticipated in H2 as France stabilizes and base effects ease.
Latest events from Guerbet
- Net loss of €112.7 million driven by impairment, with 2026 outlook negatively impacted by Raleigh site.GBT
H2 202511 Mar 2026 - 2025 revenue fell 3.5% at CER, but EBITDA margin and cash flow outlooks remain positive.GBT
Q4 2025 TU5 Feb 2026 - Q3 2025 marked a return to growth, led by Elucirem™ and LipiodolⓇ momentum.GBT
Q3 2025 TU23 Oct 2025 - Revenue and profit declined in H1 2025, leading to lower guidance and cost focus.GBT
H1 202525 Sep 2025 - H1 revenue fell 5.4% at CER, but double-digit growth is expected in H2 as France recovers.GBT
Q2 2025 TU24 Jul 2025 - Strong H1 2024 growth and profitability led to raised guidance and improved financial metrics.GBT
H1 202413 Jun 2025 - Revenue up 8.1% to €620.5m, driven by Americas and Asia, with 2024 growth above 9% expected.GBT
Q3 2024 TU13 Jun 2025 - H1 2024 revenue up 11.8% at CER, with 2024 growth and margin guidance reaffirmed.GBT
Q2 2024 TU13 Jun 2025 - 2024 revenue rose 9% like-for-like, with strong Americas and Asia growth and improved margins.GBT
Q4 2024 TU6 Jun 2025